Gene · 7508
Papers3,752
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,752
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Temozolomide, Procarbazine and Nitrosoureas in the Therapy of Malignant Gliomas: Update of Mechanisms, Drug Resistance and Therapeutic Implications. | J Clin Med | 2023 | 38068493 | PubTator, text mining | PubMed |
| Developing novel antimicrobials by combining cancer chemotherapeutics with bacterial DNA repair inhibitors. | PLoS Pathog | 2023 | 38060607 | PubTator, text mining | PubMed |
| Detection of oxaliplatin- and cisplatin-DNA lesions requires different global genome repair mechanisms that affect their clinical efficacy. | NAR Cancer | 2023 | 38058548 | PubTator, text mining | PubMed |
| Neurological disease in xeroderma pigmentosum: prospective cohort study of its features and progression. | Brain | 2023 | 38040034 | PubTator, text mining | PubMed |
| Genetic Polymorphisms Involved in Bladder Cancer: A Global Review. | Oncol Rev | 2023 | 38025894 | PubTator, text mining | PubMed |
The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1}. | Trials | 2023 | 38017457 | PubTator, text mining | PubMed |
| Gene polymorphism and prediction of toxicity to platinum-based chemotherapy in patients with gynecologic cancer. | Clin Transl Sci | 2023 | 38013655 | PubTator, text mining | PubMed |
| SNP Array Screening and Long Range PCR-Based Targeted Next Generation Sequencing for Autosomal Recessive Disease with Consanguinity: Insight from a Case of Xeroderma Pigmentosum Group C. | Genes (Basel) | 2023 | 38003022 | PubTator, text mining | PubMed |
| A naturally occurring variant of MBD4 causes maternal germline hypermutation in primates. | Genome Res | 2023 | 37984997 | PubTator, text mining | PubMed |
| A Biallelic Variant of the RNA Exosome Gene EXOSC4 Causes Translational Defects Associated with a Neurodevelopmental Disorder. | medRxiv | 2023 | 37961665 | PubTator, text mining | PubMed |
| The Biological Assessment of Shikonin and β,β-dimethylacrylshikonin Using a Cellular Myxofibrosarcoma Tumor Heterogeneity Model. | Int J Mol Sci | 2023 | 37958891 | PubTator, text mining | PubMed |
| Targeting the DNA Damage Response for Cancer Therapy. | Int J Mol Sci | 2023 | 37958890 | PubTator, text mining | PubMed |
| Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers. | Front Oncol | 2023 | 37954081 | PubTator, text mining | PubMed |
| Conformation-dependent lesion bypass of bulky arylamine-dG adducts generated from 2-nitrofluorene in epigenetic sequence contexts. | Nucleic Acids Res | 2023 | 37953358 | PubTator, text mining | PubMed |
| RNF14-dependent atypical ubiquitylation promotes translation-coupled resolution of RNA-protein crosslinks. | Mol Cell | 2023 | 37951216 | PubTator, text mining | PubMed |
| Mechanisms of E-Cigarette Vape-Induced Epithelial Cell Damage. | Cells | 2023 | 37947630 | PubTator, text mining | PubMed |
| Spatiotemporal roles of AMPK in PARP-1- and autophagy-dependent retinal pigment epithelial cell death caused by UVA. | J Biomed Sci | 2023 | 37936170 | PubTator, text mining | PubMed |
| A Novel Interaction Between RAD23A/B and Y-family DNA Polymerases. | J Mol Biol | 2023 | 37935254 | PubTator, text mining | PubMed |
| Differing structures and dynamics of two photolesions portray verification differences by the human XPD helicase. | Nucleic Acids Res | 2023 | 37933861 | PubTator, text mining | PubMed |
| Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson's disease: a prospective cohort study. | BMC Med | 2023 | 37932720 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7508/papers?page=8